Top Page
Noronex Ltd.
(Sydney:NRX)
Noronex Ltd. (NRX) vs. S&P 500 (SPY)
Noronex Ltd. Business Overview & Revenue Model
Noronex Ltd. Financial Statement Overview
| Breakdown | ||||
| Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 40.68K | 0.00 | 0.00 | 0.00 | 0.00 | Gross Profit |
| 40.68K | 0.00 | 0.00 | 0.00 | 0.00 | EBIT |
| -2.53M | -3.39M | -5.69M | -2.17M | -695.42K | EBITDA |
| -2.52M | 36.40K | 148.07K | 25.73K | -695.42K | Net Income Common Stockholders |
| -2.51M | -3.36M | -5.55M | -2.15M | -695.49K |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 913.58K | 393.75K | 2.11M | 3.01M | 1.51M | Total Assets |
| 3.81M | 3.32M | 5.05M | 5.72M | 1.51M | Total Debt |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Net Debt |
| -913.58K | -393.75K | -2.11M | -3.01M | -1.51M | Total Liabilities |
| 754.42K | 424.52K | 468.48K | 259.97K | 168.57K | Stockholders Equity |
| 3.02M | 2.85M | 4.36M | 5.11M | 1.35M |
| Cash Flow | Free Cash Flow | |||
| -2.36M | -3.12M | -5.36M | -2.06M | -571.66K | Operating Cash Flow |
| -2.36M | -3.12M | -5.28M | -1.80M | -571.66K | Investing Cash Flow |
| 412.06K | 0.00 | -80.00K | -703.93K | 0.00 | Financing Cash Flow |
| 2.47M | 1.42M | 4.46M | 4.02M | 0.00 |
Noronex Ltd. Technical Analysis
Noronex Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | AU$57.67M | 17.00 | 6.01% | ― | 8.70% | 11.11% | |
50 Neutral | $1.97B | -1.14 | -21.33% | 3.61% | 1.59% | -30.68% | |
47 Neutral | AU$8.36M | ― | -174.10% | ― | ― | 32.35% | |
41 Neutral | AU$52.47M | ― | -5.23% | ― | ― | 54.26% | |
28 Underperform | AU$6.53M | ― | -31.24% | ― | ― | 30.16% |
Noronex Ltd. Corporate Events
Noronex Limited has announced a change in the interest of its director, James Thompson, in the company’s securities. The change involves the acquisition of 500,000 quoted options through an on-market purchase, increasing the total number of indirectly held quoted options to 10,646,343. This transaction reflects a strategic move by the director, potentially indicating confidence in the company’s future performance.
Noronex Limited has commenced diamond drilling at the Fiesta Copper Project in Namibia’s Kalahari Copper Belt to explore depth extensions and gain geological insights. This initiative, funded by South32 Limited under an earn-in agreement, aims to confirm significant copper-silver mineralization and assess the potential size of the Fiesta system. The drilling program will test the full width and depth of the mineralization, with plans for further exploration to extend the system’s strike, which remains open to the west.
Noronex Limited has experienced a change in the interests of a substantial holder, Cumulus Wealth, which now holds a 12.45% voting power in the company, up from 8.84%. This increase in voting power could potentially impact Noronex’s decision-making processes and influence its strategic direction, reflecting a significant shift in stakeholder dynamics.
Noronex Limited has announced a change in the interests of its director, Robert Klug, involving the acquisition of 1,000,000 ordinary shares and the disposal of 1,000,000 unquoted options. This transaction results in Mr. Klug holding a total of 2,000,000 ordinary shares and 100,000 quoted options. The exercise of unquoted options was valued at $14,000, indicating a strategic adjustment in the director’s investment portfolio, which could reflect confidence in the company’s future performance.
Noronex Limited has experienced a change in the voting power of its substantial holder, Larchmont Holdings Pty Ltd, due to the issuance of new shares following an option exercise. This change has resulted in a dilution of Larchmont Holdings’ voting power from 14.22% to 12.95%, although the number of shares held remains the same at 72,160,206. The adjustment in voting power could impact the company’s shareholder dynamics and influence within the company.
Noronex Limited has issued 48,659,828 fully paid ordinary shares, as announced in their recent filing. This issuance is exempt from the usual disclosure requirements under section 708A(5) of the Corporations Act 2001, allowing the shares to be sold without additional disclosure. The company confirms compliance with relevant legal provisions and states there is no undisclosed information that would affect investors’ assessments.
Noronex Ltd. has announced the quotation of 41,993,162 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of March 31, 2025. This move is part of the company’s strategic efforts to increase liquidity and broaden its investor base, potentially strengthening its market position and providing more opportunities for stakeholders.
Noronex Limited has announced the application for the quotation of its securities, specifically 2,666,666 ordinary fully paid shares, on the Australian Securities Exchange (ASX) under the code NRX. This move signifies a strategic step for Noronex Limited, potentially enhancing its liquidity and market presence, which could have implications for its stakeholders by increasing the company’s visibility and attractiveness to investors.
Noronex Limited has announced the issuance of 9,000,000 performance rights as part of an employee incentive scheme. These unquoted equity securities are not intended to be listed on the ASX, reflecting the company’s strategy to incentivize and retain its workforce, potentially impacting its operational efficiency and employee engagement.
Noronex Limited has raised $710,703 through the early exercise of options by directors and major shareholders, which will be used to advance its copper exploration programs in the Kalahari Copper Belt. This funding, along with an expected $750,000 from an earn-in agreement with South32, will enable Noronex to commence diamond drilling at the Fiesta Project in Namibia and accelerate exploration activities on its 100%-owned projects, including soil geochemistry in Botswana and uranium prospecting in Namibia. The option exercise enhances Noronex’s financial flexibility and supports its strategic focus on expanding its mineral resource base.
Noronex Limited announced a change in the director’s interest, specifically involving James Thompson. The change involved the exercise of unquoted options, resulting in the acquisition of 7,608,528 fully paid ordinary shares and the disposal of the same number of unquoted options. This transaction reflects a strategic adjustment in the director’s holdings, potentially impacting the company’s share distribution and signaling confidence in the company’s future prospects.
Noronex Limited has announced the issuance of 7,608,528 fully paid ordinary shares, which are exempt from disclosure requirements under section 708A(5) of the Corporations Act 2001. This move indicates compliance with regulatory provisions and ensures that there is no undisclosed information that investors would need to make informed decisions regarding the company’s financial standing or the rights attached to these shares.
Noronex Limited has announced the quotation of 7,608,528 ordinary fully paid securities on the Australian Securities Exchange (ASX) under the code NRX. This move follows the exercise of options or conversion of other convertible securities, which could potentially enhance the company’s liquidity and broaden its shareholder base, impacting its market presence positively.
Noronex Ltd. has released its interim financial report for the half-year ending December 31, 2024. The report includes various financial statements such as the condensed consolidated statement of profit or loss, financial position, changes in equity, and cash flows, along with notes to the interim consolidated financial statements. This release provides insights into the company’s financial health and operational performance, which are crucial for stakeholders to assess the company’s market positioning and future prospects.
Noronex Limited has been granted two new prospecting licenses in Botswana, adjacent to its Damara Copper Project in Namibia, marking a significant step in its exploration activities in the Kalahari Copper Belt. This strategic move aligns with the recent BHP-Cobre partnership, potentially enhancing Noronex’s industry positioning and offering promising opportunities for future copper discoveries, which could have implications for stakeholders and the broader market.
Noronex Limited announced that its Chief Geologist, Bruce Hooper, will host a webinar to discuss the latest exploration results from the Fiesta Copper Project in Namibia. The webinar will provide updates on the company’s exploration activities across its extensive land-holdings in the Kalahari Copper Belt in Namibia and Botswana, reflecting its ongoing commitment to leveraging modern exploration techniques to enhance resource discovery.
Noronex Limited has reported significant copper-silver mineralization at its Fiesta Copper Project in Namibia, with a major 500m step-out confirming extensive mineral deposits. The company plans to further explore these promising findings with diamond drilling, aiming to expand and define the system’s potential, which could significantly enhance its industry standing and stakeholder value.
Noronex Limited announced the receipt of an additional payment of N$1 million for the Dordabis asset in Namibia, which is part of a larger sale agreement expected to total N$13.68 million. This transaction is part of Noronex’s strategy to concentrate on discovering large-scale copper deposits in Namibia’s Kalahari Copper Belt, notably at the Humpback Copper Project. The additional funds from this transaction will enhance Noronex’s exploration activities across its Namibian and Canadian projects, including new uranium and copper ventures. The deal’s amendments are due to local transfer approval delays, with the remaining balance expected in the next quarter, allowing the buyer, Umino (Pty) Ltd, to expedite work on the Dordabis site.
Noronex Limited has announced the cessation of 18,000,000 securities, specifically options expiring on February 9, 2025, which were not exercised or converted. This update reflects a change in the company’s issued capital, impacting its financial structure and potentially influencing investor perceptions.